On January 29, 2025, MBI researchers joined the latest Cure Group 4 Consortium meeting, connecting experts from the US, Canada, and Germany. The team discussed preparations for two upcoming FDA-approved clinical trials and set new research goals.
Dr. Gene Hwang, head of Oncology at Children’s National in Washington, D.C., highlighted the impact of these efforts, stating, “It’s incredible how many exciting, translatable findings and trials are being generated by this group.”
Stay tuned for more updates as this groundbreaking research moves forward!
